Cargando…
Discovery of VIP236, an αvβ3-Targeted Small-Molecule–Drug Conjugate with Neutrophil Elastase-Mediated Activation of 7-Ethyl Camptothecin Payload for Treatment of Solid Tumors
SIMPLE SUMMARY: The goal of this work was to improve the tumor selectivity of chemotherapy to reduce side effects and improve efficacy. We designed a drug called VIP236 that delivers chemotherapy directly to tumors due to a specialized “homing feature” that binds to αvβ3 integrins. Solid tumors expr...
Autores principales: | Lerchen, Hans-Georg, Stelte-Ludwig, Beatrix, Heroult, Melanie, Zubov, Dmitry, Gericke, Kersten Matthias, Wong, Harvey, Frigault, Melanie M., Johnson, Amy J., Izumi, Raquel, Hamdy, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486604/ https://www.ncbi.nlm.nih.gov/pubmed/37686656 http://dx.doi.org/10.3390/cancers15174381 |
Ejemplares similares
-
A Small Molecule–Drug Conjugate (SMDC) Consisting of a Modified Camptothecin Payload Linked to an α(V)ß(3) Binder for the Treatment of Multiple Cancer Types
por: Lerchen, Hans-Georg, et al.
Publicado: (2022) -
Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription
por: Frigault, Melanie M., et al.
Publicado: (2023) -
P1269: VIP152 IS A NOVEL CDK9 INHIBITOR WITH IMPROVED SELECTIVITY, TARGET MODULATION, AND CARDIAC SAFETY IN PATIENTS WITH LYMPHOMA
por: Frigault, M., et al.
Publicado: (2022) -
IL3RA-Targeting Antibody–Drug Conjugate BAY-943 with a Kinesin Spindle Protein Inhibitor Payload Shows Efficacy in Preclinical Models of Hematologic Malignancies
por: Kirchhoff, Dennis, et al.
Publicado: (2020) -
A Novel NAMPT Inhibitor-Based Antibody–Drug
Conjugate Payload Class for Cancer Therapy
por: Böhnke, Niels, et al.
Publicado: (2022)